Brainsway (BWAY) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BrainsWay Ltd., a pioneering firm in noninvasive neurostimulation treatments for mental health, is expanding its reach in East Asia with the addition of 15 Deep Transcranial Magnetic Stimulation systems in Taiwan and South Korea. This move underscores the company’s success in these key markets and aligns with its strategy to enhance global access to its innovative Deep TMS technology. The deployment of these systems is set to meet growing demand and further BrainsWay’s mission to improve mental health treatment across the globe.
For further insights into BWAY stock, check out TipRanks’ Stock Analysis page.
